News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,467 Results
Type
Article (43053)
Company Profile (282)
Press Release (694113)
Multimedia
Podcasts (92)
Webinars (24)
Section
Business (207618)
Career Advice (2070)
Deals (35795)
Drug Delivery (126)
Drug Development (82433)
Employer Resources (176)
FDA (16602)
Job Trends (15181)
News (351074)
Policy (33258)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2690)
Accelerated approval (42)
Adcomms (26)
Allergies (161)
Alliances (50458)
ALS (194)
Alzheimer's disease (1775)
Antibody-drug conjugate (ADC) (370)
Approvals (16912)
Artificial intelligence (617)
Autoimmune disease (224)
Automation (51)
Bankruptcy (365)
Best Places to Work (11748)
BIOSECURE Act (21)
Biosimilars (204)
Biotechnology (181)
Bladder cancer (178)
Brain cancer (63)
Breast cancer (693)
Cancer (5368)
Cardiovascular disease (452)
Career advice (1758)
Career pathing (41)
CAR-T (305)
CDC (55)
Celiac Disease (2)
Cell therapy (812)
Cervical cancer (41)
Clinical research (70912)
Collaboration (1925)
Company closure (4)
Compensation (1273)
Complete response letters (70)
COVID-19 (2797)
CRISPR (103)
C-suite (998)
Cystic fibrosis (150)
Data (7101)
Decentralized trials (3)
Denatured (29)
Depression (158)
Dermatology (57)
Diabetes (557)
Diagnostics (6931)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (305)
Drug pricing (195)
Drug shortages (29)
Duchenne muscular dystrophy (267)
Earnings (91435)
Editorial (63)
Employer branding (22)
Employer resources (155)
Events (120270)
Executive appointments (1051)
FDA (20042)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1650)
Gene editing (216)
Generative AI (56)
Gene therapy (667)
GLP-1 (1042)
Government (4781)
Grass and pollen (6)
Guidances (397)
Healthcare (19194)
HIV (75)
Huntington's disease (53)
IgA nephropathy (92)
Immunology and inflammation (274)
Immuno-oncology (81)
Indications (157)
Infectious disease (3116)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (275)
Interviews (320)
IPO (16719)
IRA (50)
Job creations (3758)
Job search strategy (1467)
JPM (58)
Kidney cancer (19)
Labor market (92)
Layoffs (566)
Leadership (35)
Legal (8108)
Liver cancer (100)
Longevity (29)
Lung cancer (719)
Lymphoma (410)
Machine learning (54)
Management (59)
Manufacturing (924)
MASH (178)
Medical device (13980)
Medtech (14057)
Mergers & acquisitions (20240)
Metabolic disorders (1425)
mRNA (182)
Multiple sclerosis (175)
NASH (18)
Neurodegenerative disease (391)
Neuropsychiatric disorders (100)
Neuroscience (3185)
Neurotech (1)
NextGen: Class of 2026 (6614)
Non-profit (4666)
Now hiring (73)
Obesity (670)
Opinion (280)
Ovarian cancer (185)
Pain (233)
Pancreatic cancer (256)
Parkinson's disease (342)
Partnered (34)
Patents (556)
Patient recruitment (594)
Peanut (60)
People (60651)
Pharmaceutical (65)
Pharmacy benefit managers (32)
Phase 1 (22124)
Phase 2 (31201)
Phase 3 (23236)
Pipeline (7145)
Policy (311)
Postmarket research (2606)
Preclinical (9459)
Press Release (67)
Prostate cancer (276)
Psychedelics (52)
Radiopharmaceuticals (304)
Rare diseases (1004)
Real estate (6077)
Recruiting (72)
Regulatory (25282)
Reports (54)
Research institute (2511)
Resumes & cover letters (357)
Rett syndrome (33)
RNA editing (17)
RSV (86)
Schizophrenia (164)
Series A (277)
Series B (203)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (47)
Startups (3724)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (60)
Vaccines (1078)
Venture capital (99)
Weight loss (428)
Women's health (109)
Worklife (19)
Date
Last 7 days (644)
Last 30 days (2551)
Last 365 days (30294)
2026 (8091)
2025 (30572)
2024 (35639)
2023 (40535)
2022 (51689)
2021 (56273)
2020 (54653)
2019 (47239)
2018 (35601)
2017 (32702)
2016 (32178)
2015 (38225)
2014 (31919)
2013 (26973)
2012 (29100)
2011 (29764)
2010 (27847)
Location
Africa (765)
Alabama (91)
Alaska (7)
Arizona (331)
Arkansas (13)
Asia (40176)
Australia (6601)
California (12312)
Canada (3536)
China (1239)
Colorado (523)
Connecticut (531)
Delaware (367)
Europe (88119)
Florida (1852)
Georgia (396)
Hawaii (3)
Idaho (62)
Illinois (967)
India (81)
Indiana (561)
Iowa (23)
Japan (488)
Kansas (131)
Kentucky (44)
Louisiana (39)
Maine (85)
Maryland (1494)
Massachusetts (8885)
Michigan (347)
Minnesota (684)
Mississippi (6)
Missouri (140)
Montana (34)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3276)
New Mexico (30)
New York (3257)
North Carolina (1593)
North Dakota (10)
Northern California (6076)
Ohio (376)
Oklahoma (22)
Oregon (44)
Pennsylvania (2490)
Puerto Rico (27)
Rhode Island (51)
South America (1144)
South Carolina (76)
South Dakota (1)
Southern California (4847)
Tennessee (202)
Texas (1936)
United States (43790)
Utah (370)
Vermont (1)
Virginia (297)
Washington D.C. (80)
Washington State (991)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
737,467 Results for "safeguard scientifics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
March 30, 2026
·
4 min read
Press Releases
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
March 24, 2026
·
7 min read
Press Releases
First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
December 19, 2025
·
6 min read
Press Releases
Boston Scientific announces agreement to acquire Penumbra, Inc.
January 16, 2026
·
15 min read
Opinion
Extending Scientific Rigor From Bench to Boardroom
Many scientists-turned-CEOs paradoxically abandon scientific principles when it comes to commercializing their innovations. But applying the scientific method to business decisions can help life science entrepreneurs avoid common pitfalls, attract investment and ultimately bring transformative technologies to market.
February 19, 2026
·
6 min read
·
Oded Ben-Joseph
Press Releases
Etienna Bio, Inc. Announces Formation of Scientific Advisory Board with Renowned UMass Chan Leaders
February 12, 2026
·
4 min read
Press Releases
Thermo Fisher Scientific Increases Quarterly Dividend
February 26, 2026
·
1 min read
Press Releases
Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.
March 25, 2026
·
3 min read
Press Releases
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM
March 31, 2026
·
3 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership
December 10, 2025
·
6 min read
1 of 73,747
Next
